Canaccord Views Doximity's Post-Earnings Selloff as Overreaction, Sees Long-Term Upside

Canaccord believes Doximity, Inc.'s (DOCS) post-earnings selloff was an overreaction and sees long-term upside for the company.

18 Feb, 06:12 — 18 Feb, 06:12